TORTORA , Annalisa

Treatment of Hepatitis C Virus (HCV) with direct acting antivirals (DAAs) is able to achieve the cure of infection in almost the totality of patients, independently of patients and virus characteristics, using short treatment schedules, and without the need of ribavirin. The high cost of DAAs is the main limiting factor for universal treatment...